Cooper Financial Group decreased its stake in Becton, Dickinson and Company (NYSE:BDX – Free Report) by 4.8% during the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 4,316 shares of the medical instruments supplier’s stock after selling 217 shares during the period. Cooper Financial Group’s holdings in Becton, Dickinson and Company were worth $979,000 at the end of the most recent reporting period.
A number of other hedge funds and other institutional investors have also added to or reduced their stakes in the stock. Livelsberger Financial Advisory bought a new stake in Becton, Dickinson and Company in the third quarter valued at $26,000. Ashton Thomas Securities LLC bought a new stake in Becton, Dickinson and Company in the 3rd quarter valued at about $33,000. Tompkins Financial Corp boosted its stake in Becton, Dickinson and Company by 44.2% during the 3rd quarter. Tompkins Financial Corp now owns 150 shares of the medical instruments supplier’s stock valued at $36,000 after purchasing an additional 46 shares during the period. Sound Income Strategies LLC grew its position in Becton, Dickinson and Company by 35.8% in the 3rd quarter. Sound Income Strategies LLC now owns 167 shares of the medical instruments supplier’s stock worth $40,000 after purchasing an additional 44 shares during the last quarter. Finally, Kennebec Savings Bank acquired a new stake in shares of Becton, Dickinson and Company in the third quarter valued at approximately $46,000. Institutional investors and hedge funds own 86.97% of the company’s stock.
Wall Street Analyst Weigh In
Several equities analysts have recently issued reports on BDX shares. Citigroup upgraded Becton, Dickinson and Company from a “neutral” rating to a “buy” rating and boosted their price objective for the stock from $255.00 to $275.00 in a research report on Tuesday, October 1st. Evercore ISI boosted their price target on Becton, Dickinson and Company from $286.00 to $290.00 and gave the stock an “outperform” rating in a research report on Tuesday, October 1st. Finally, StockNews.com cut shares of Becton, Dickinson and Company from a “buy” rating to a “hold” rating in a research note on Wednesday, December 18th. One equities research analyst has rated the stock with a hold rating and six have issued a buy rating to the company’s stock. Based on data from MarketBeat, Becton, Dickinson and Company has a consensus rating of “Moderate Buy” and an average target price of $283.50.
Insiders Place Their Bets
In other Becton, Dickinson and Company news, EVP Roland Goette sold 4,483 shares of Becton, Dickinson and Company stock in a transaction that occurred on Friday, December 6th. The shares were sold at an average price of $221.01, for a total transaction of $990,787.83. Following the transaction, the executive vice president now directly owns 24,345 shares in the company, valued at approximately $5,380,488.45. The trade was a 15.55 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, EVP Shana Carol Neal sold 788 shares of the stock in a transaction on Tuesday, January 7th. The shares were sold at an average price of $235.00, for a total value of $185,180.00. Following the completion of the sale, the executive vice president now owns 16,201 shares of the company’s stock, valued at $3,807,235. The trade was a 4.64 % decrease in their position. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 8,747 shares of company stock worth $1,949,520. 0.36% of the stock is owned by insiders.
Becton, Dickinson and Company Stock Up 1.1 %
BDX opened at $236.29 on Tuesday. The company has a debt-to-equity ratio of 0.69, a quick ratio of 0.74 and a current ratio of 1.17. The company has a market capitalization of $68.53 billion, a PE ratio of 39.78, a P/E/G ratio of 1.64 and a beta of 0.39. The stock’s fifty day moving average is $226.95 and its 200-day moving average is $232.49. Becton, Dickinson and Company has a one year low of $218.75 and a one year high of $248.42.
Becton, Dickinson and Company (NYSE:BDX – Get Free Report) last issued its quarterly earnings results on Thursday, November 7th. The medical instruments supplier reported $3.81 EPS for the quarter, topping the consensus estimate of $3.77 by $0.04. Becton, Dickinson and Company had a net margin of 8.55% and a return on equity of 14.89%. The firm had revenue of $5.44 billion for the quarter, compared to analysts’ expectations of $5.38 billion. During the same period in the previous year, the business earned $3.42 earnings per share. Becton, Dickinson and Company’s revenue for the quarter was up 6.9% compared to the same quarter last year. On average, equities analysts predict that Becton, Dickinson and Company will post 14.43 EPS for the current fiscal year.
Becton, Dickinson and Company Increases Dividend
The firm also recently announced a quarterly dividend, which was paid on Tuesday, December 31st. Investors of record on Monday, December 9th were issued a dividend of $1.04 per share. This represents a $4.16 dividend on an annualized basis and a yield of 1.76%. This is a boost from Becton, Dickinson and Company’s previous quarterly dividend of $0.95. The ex-dividend date was Monday, December 9th. Becton, Dickinson and Company’s dividend payout ratio (DPR) is presently 70.03%.
Becton, Dickinson and Company Profile
Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company operates in three segments: BD Medical, BD Life Sciences, and BD Interventional.
Read More
- Five stocks we like better than Becton, Dickinson and Company
- What is the Dow Jones Industrial Average (DJIA)?
- 2 Stocks to Gain From Trump Universal Tariffs on Critical Imports
- ETF Screener: Uses and Step-by-Step Guide
- Rigetti Computing, Inc.: Buy, Sell, or Hold for 2025
- The 3 Best Retail Stocks to Shop for in August
- Delta Can Fly to New Highs in 2025; Here’s Why
Want to see what other hedge funds are holding BDX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Becton, Dickinson and Company (NYSE:BDX – Free Report).
Receive News & Ratings for Becton Dickinson and Company Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Becton Dickinson and Company and related companies with MarketBeat.com's FREE daily email newsletter.